Unveiling the Reperfusion Paradox
Manesh R. Patel, MD
Biomarkers of the Storm: Decoding IRI’s Signature
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Reperfusion Paradox: The Hidden Threat in STEMI After PCI and the Quest for Effective Therapeutics
What’s on the Horizon for IRI Management?
The Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality
Optimizing Your Pharmacologic Approach to Reversing Anticoagulation for ICH
David Seiffge, MD
Natalie Kreitzer, MD, MS
W. Brian Gibler, MD, FACEP, FACC, FAHA
Audience Q&A with Panel
Adrian R. Parry-Jones, FRCP, PhD
Hiren C. Patel, PhD, FRCS
Thorsten Steiner, MD, PhD, MME
Emerging Data on Reversal and Repletion for Anticoagulated Patients with ICH: The Neurocritical Care Perspective
What’s New in Treating the Anticoagulated Patient with ICH?
ESO Guidelines for the Management of ICH in the Anticoagulated Patient
Neurosurgical Management of ICH: Making Sense of ENRICH, SWITCH, STICH and MISTIE
Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Deborah Siegal, MD, MSc, FRCPC
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
Alfonso J. Tafur, MD, MS, MBA, RPVI
Right from the Onset: PE Diagnosis, Management
Bruce L. Davidson, MD, MPH
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.